Aurora Cannabis (ACB) Scheduled to Post Quarterly Earnings on Monday
Aurora Cannabis (NYSE:ACB – Get Free Report) is set to issue its quarterly earnings data on Monday, September 18th.
Aurora Cannabis (NYSE:ACB – Get Free Report) last issued its earnings results on Thursday, August 10th. The company reported ($0.04) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.04. The firm had revenue of $55.92 million for the quarter, compared to analyst estimates of $46.80 million. Aurora Cannabis had a negative return on equity of 30.47% and a negative net margin of 88.27%. On average, analysts expect Aurora Cannabis to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Aurora Cannabis Price Performance
Shares of NYSE ACB opened at $0.98 on Friday. The business’s 50 day moving average price is $0.55 and its 200 day moving average price is $0.60. The firm has a market cap of $390.11 million, a P/E ratio of -1.89 and a beta of 2.58. Aurora Cannabis has a 52 week low of $0.43 and a 52 week high of $1.62. The company has a quick ratio of 3.16, a current ratio of 4.08 and a debt-to-equity ratio of 0.33.
Hedge Funds Weigh In On Aurora Cannabis
A number of institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. boosted its holdings in Aurora Cannabis by 72.8% during the second quarter. Goldman Sachs Group Inc. now owns 1,269,306 shares of the company’s stock worth $679,000 after buying an additional 534,615 shares in the last quarter. Ergoteles LLC boosted its holdings in Aurora Cannabis by 1,012.9% during the second quarter. Ergoteles LLC now owns 147,482 shares of the company’s stock worth $79,000 after buying an additional 134,230 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Aurora Cannabis by 37.8% during the second quarter. JPMorgan Chase & Co. now owns 341,751 shares of the company’s stock worth $2,970,000 after buying an additional 93,747 shares in the last quarter. Gallagher Fiduciary Advisors LLC purchased a new stake in Aurora Cannabis during the first quarter worth $34,000. Finally, Bank of America Corp DE boosted its holdings in Aurora Cannabis by 38.5% during the first quarter. Bank of America Corp DE now owns 321,326 shares of the company’s stock worth $224,000 after buying an additional 89,300 shares in the last quarter. Hedge funds and other institutional investors own 11.17% of the company’s stock.
Aurora Cannabis Company Profile
(Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Aurora Cannabis wasn’t on the list.
While Aurora Cannabis currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
No Byline Policy
Editorial Guidelines
Corrections Policy
Source